Science ❯Medical Research ❯Vaccine Technology
Clinical Trials COVID-19 Vaccines Pharmaceutical Companies Infectious Diseases Efficacy Studies Vaccine Mutations COVID-19 Response Infectious Disease Control Safety Concerns Nobel Prize in Medicine Public Health Implications
Kennedy says mRNA vaccines underperform against respiratory infections to justify redirecting funding toward broader, more established platforms.
